August 17, 2010
Enterprise Productivity Lecture at ACDRS
Cognigen CEO Ted Grasela will speak on enterprise productivity during Session 1 of the American Course on Drug Development and Regulatory Sciences (ACDRS), which starts October 25, 2010, in San Francisco. Grasela will discuss the concept that model-based drug development can be used to guide the design, analysis, and interpretation of innovative trials that can be done faster, at less cost, and with a greater yield of information than possible with the current empirical drug development paradigm.
ACDRS Session 1 is titled: The Pharmaceutical Development Enterprise: Current and Future Perspectives. In addition to lecturing, Grasela will chair the session along with Fritz Bühler, MD, of the University of Basel, Switzerland.
The 2010-2012 cycle of ACDRS consists of 23 teaching days divided into 6 sessions over a period of 2 years. For details and to register, visit the ACDRS website.
